World Acne Treatment Market Assessed & Forecast in Topical Daedal Research Report Published at MarketPublishers.com
10 Feb 2015 • by Natalie Aster
LONDON – The worldwide acne sector represents a small chunk of the overall dermatology market. Acne is treated by both over-the-counter (OTC) and prescription drugs. The acne market is mainly genericised and is moderately served by the presently marketed top prescribed drugs such as DORYX, EPIDUO and SOLODYN. Geography-wise, the USA is the largest acne products market with close to 50 million people having acne.
Worldwide, the acne market has an extremely small size, however, it holds huge potential stimulated primarily by higher levels of personal income, increased consumption of high-fat fast food, growing health care expenditures, and rising spending on drugs from a slew of emerging economies. The acne marketplace is also characterised by immense R&D opportunities. Novel laser treatments for acne, as well as technology-driven products are the main trends in the acne industry. Still, the global acne market’s growth could be challenged by the growing competition from newish medications high drug prices, regulatory issues, as well as the ill effects of drugs.
Topical research study “Global Acne Treatment Market: Trends and Opportunities (2014-2019)” worked out by Daedal Research provides true, deep insights into the acne market with an emphasis on global prescription drug products. The research report provides estimates of the market size and growth of the world acne market, the tempo of growth of acne market in different regions and the growth and composition of topical and oral acne drugs. Furthermore, the research publication includes an analysis of the top prescription drugs for treating acne. It also offers a discussion of the key factors propelling growth in the sector, top trends and challenges that acne drug manufacturers are facing. In addition, the report provides a review of the leading players in the market, including Valeant Pharmaceuticals, Foamix Pharmaceuticals, Actavis plc and Dermira.
Global Acne Treatment Market: Trends and Opportunities (2014-2019)
Published: January, 2015
Price: US$ 900.00
Other Global Markets Reports by Daedal Research:
- Global Biosimilar Market Trends & Opportunities: 2015 Edition
- Global Spinal Cord Stimulation Market: Trends & Opportunities (2014-19)
- Global Automotive LED Lighting Market: Trends and Opportunities (2014-2019)
More topical studies by the publisher can be found at Daedal Research page.